Cyprium Therapeutics, Inc. ("Cyprium") is focused on the development of novel therapies for the treatment of Menkes disease and related copper metabolism disorders. In March 2017, Cyprium entered into a Cooperative Research and Development Agreement ("CRADA") with the Eunice Kennedy Shriver National Institute of Child Health and Human Development ("NICHD"), part of the NIH, to advance the clinical development of CUTX-101 (Copper Histidinate injection) for the treatment of Menkes disease. In addition, Cyprium and NICHD entered into a worldwide, exclusive license agreement to develop and commercialize adeno-associated virus (AAV)-based gene therapy, called AAV-ATP7A, to deliver working copies of the copper transporter that is defective in patients with Menkes disease, and to be used in combination with CUTX-101. CUTX-101 was granted FDA Breakthrough Therapy, Fast Track and Rare Pediatric Disease Designations, and both CUTX-101 and AAV-ATP7A have received FDA Orphan Drug Designation previously. Additionally, the European Medicines Agency previously granted Orphan Drug Designation to CUTX-101. Cyprium was founded by Fortress Biotech, Inc. (Nasdaq: FBIO) and is based in New York City.
View Top Employees from Cyprium TherapeuticsWebsite | http://www.cypriumtx.com |
Revenue | $202000 |
Employees | 1 (1 on RocketReach) |
Address | 2 Gansevoort St, Fl 9, New York City, New York 10014, US |
Phone | (212) 574-2824 |
Industry | Business Services General, Business Services |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Cyprium Therapeutics employee's phone or email?
The Cyprium Therapeutics annual revenue was $202000 in 2024.
Lung Yam is the Co-Founder, Chief Executive Officer of Cyprium Therapeutics.
1 people are employed at Cyprium Therapeutics.
Cyprium Therapeutics is based in New York City, New York.
The NAICS codes for Cyprium Therapeutics are [54171, 5417, 541713, 54, 541].
The SIC codes for Cyprium Therapeutics are [873, 87].